selected publications
-
academic article
- Medicinal chemistry applied to a synthetic protein: Development of highly potent HIV entry inhibitors. Proceedings of the National Academy of Sciences of the United States of America. 101:16460-16465. 2004
- CCR2 and CCR5 receptor-binding properties of herpesvirus-8 vMIP-II based on sequence analysis and its solution structure: Solution structure of vMIP-II. Federation of European Biochemical Societies. 268:2948-2959. 2001
- High-Resolution NMR Structure of the Chemically-Synthesized Melanocortin Receptor Binding Domain AGRP(87?132) of the Agouti-Related Protein. Biochemistry. 40:15520-15527. 2001
- Comparison of the Structure of vMIP-II with Eotaxin-1, RANTES, and MCP-3 Suggests a Unique Mechanism for CCR3 Activation. Biochemistry. 39:12837-12844. 2000
- Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants. Journal of Virology. 73:3544-3550. 1999
- Aminooxypentane-RANTES, an Inhibitor of R5 Human Immunodeficiency Virus Type 1, Increases the Interferon gamma to Interleukin 10 Ratio without Impairing Cellular Proliferation. AIDS Research and Human Retroviruses. 15:861-867. 1999
- Characterization of Agouti-Related Protein Binding to Melanocortin Receptors 1999
- NMR structure of a minimized human agouti related protein prepared by total chemical synthesis 1999
- The chemokine receptor antagonist AOP-RANTES reduces monocyte infiltration in experimental glomerulonephritis 1999
- Total chemical synthesis and high-resolution crystal structure of the potent anti-HIV protein AOP-RANTES 1999
- Accessibility of selenomethionine proteins by total chemical synthesis: structural studies of human herpesvirus-8 MIP-II. Federation of European Biochemical Societies. 441:77-82. 1998